Publications
34
Citations
3,695
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2017
- Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2026
- Standardizing the Clinical Approach to Cancer Therapy‐Related Cardiac Dysfunction: Applying Cardio‐Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers
Cancer Medicine · 2026
- NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025
Journal of the National Comprehensive Cancer Network · 2025
- Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2025
- Efficacy and Safety of Olomorasib with Pembrolizumab+Chemotherapy as First Line Treatment in Patients with KRAS G12C-Mutant Advanced NSCLC
Pneumologie · 2025
- Abstract CT196: Phase 1 dose escalation and expansion study of the PTK7-targeted antibody-drug conjugate DAY301 in patients with locally advanced or metastatic solid tumors
Cancer Research · 2025
- Non–Small Cell Lung Cancer, Version 4.2024
Journal of the National Comprehensive Cancer Network · 2024
- Mesothelioma: Pleural, Version 1.2024
Journal of the National Comprehensive Cancer Network · 2024
- 1487 Results from a phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancer
2024
- NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
Journal of the National Comprehensive Cancer Network · 2023
- Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors
Cancer Research · 2023
- Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023
- Correction to “Effect of Paclitaxel Stereochemistry on X-ray-Triggered Release of Paclitaxel from CaWO<sub>4</sub>/Paclitaxel-Coloaded PEG-PLA Nanoparticles”
Molecular Pharmaceutics · 2023
- Corrigendum to “Radioluminescent nanoparticles for radiation-controlled release of drugs” [Journal of Controlled Release 303 (2019) 237–252]
Journal of Controlled Release · 2023
- Immunotherapy in Lung Cancer: Current Landscape and Future Directions
Frontiers in Immunology · 2022
- Journal of the National Comprehensive Cancer Network×7
- Cancer Research×3
- Journal of Pain and Symptom Management×2
- Journal of Controlled Release×2
- Molecular Pharmaceutics×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile